Actively Recruiting
Study of Lumbrokinase Treatment for Adults with Long Covid, Post-treatment Lyme Disease Syndrome, or Chronic Fatigue Syndrome
Led by Icahn School of Medicine at Mount Sinai · Updated on 2026-03-13
120
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of Lumbrokinase LK, a dietary supplement, in adults with Long Covid, Post-treatment Lyme Disease Syndrome PTLDS, and Myalgic EncephalomyelitisChronic Fatigue Syndrome MECFS. This pilot multi-arm clinical trial aims to investigate the feasibility of Lumbrokinase as an intervention across these three conditions, which share overlapping symptoms and impacts on health. The study is sponsored by the Icahn School of Medicine at Mount Sinai and includes adults aged 18 and older. Participants in this study will take Boluoke4 brand lumbrokinase capsules, each containing 300,000 functional units, twice daily for a total of 6 weeks. The trial includes three experimental groups, one for each condition Long Covid, Post-treatment Lyme Disease Syndrome, and MECFS. There is no randomization or placebo control, and all participants receive the same dose and schedule of Lumbrokinase. Throughout the 12-week study period, participants will be monitored and assessed with various tools to measure quality of life, physical function, cognitive ability, symptoms, and mental health. Assessments include the EuroQol Visual Analogue Scale, 10-Meter Walk Test, cognitive batteries, and symptom questionnaires like the Fatigue Severity Scale and anxiety and depression screens. Safety and adherence will be tracked, and data collected up to 12 weeks after starting the treatment.
CONDITIONS
Brief Title
Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Research Team
D
David Putrino, PhD, PT
M
Mackenzie Doerstling, MPH
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here